Risk of stomach cancer in patients with peptic ulcer disease

被引:28
作者
Hansson, LE [1 ]
机构
[1] Mora Hosp, Dept Surg, S-79285 Mora, Sweden
关键词
D O I
10.1007/s002689910050
中图分类号
R61 [外科手术学];
学科分类号
摘要
The relation between peptic ulcer and stomach cancer has long been disputed, but there is accumulating evidence that gastric ulcer disease is positively associated and duodenal ulcerations negatively associated with the risk of developing stomach cancer. As Helicobacter pylori infection is associated with both types of ulceration and stomach cancer. the varying outcomes of the infection indicate that factors other than the infection must be of importance. At present, there is no convincing evidence that pharmacologic inhibition of acid secretion for treatment of peptic ulcer increases the risk of stomach cancer. However, some recent studies indicate that prolonged treatment with proton pump inhibitors may accelerate the development of atrophic gastritis, a risk factor for stomach cancer, in individuals infected with H. pylori. It has repeatedly been shown that there is an at least twofold increased risk of stomach cancer 15 gears after gastric resection for peptic ulcer disease, and that the risk increases with the passage of time. Whether vagotomy has the same risk-increasing effect is still unclear.
引用
收藏
页码:315 / 320
页数:6
相关论文
共 93 条
[1]   GASTRIC-CANCER AFTER GASTRECTOMY [J].
ARNTHORSSON, G ;
TULINIUS, H ;
EGILSSON, V ;
SIGVALDASON, H ;
MAGNUSSON, B ;
THORARINSSON, H .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (03) :365-367
[2]   THE COHORT EFFECT AND HELICOBACTER-PYLORI [J].
BANATVALA, N ;
MAYO, K ;
MEGRAUD, F ;
JENNINGS, R ;
DEEKS, JJ ;
FELDMAN, RA .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (01) :219-221
[3]   INHIBITORS OF ENDOGENOUS NITROSATION - MECHANISMS AND IMPLICATIONS IN HUMAN CANCER PREVENTION [J].
BARTSCH, H ;
OHSHIMA, H ;
PIGNATELLI, B .
MUTATION RESEARCH, 1988, 202 (02) :307-324
[4]   Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole [J].
Berstad, AE ;
Hatlebakk, JG ;
Maartmann-Moe, H ;
Berstad, A ;
Brandtzaeg, P .
GUT, 1997, 41 (06) :740-747
[5]   HELICOBACTER-PYLORI - ITS ROLE IN DISEASE [J].
BLASER, MJ .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (03) :386-393
[6]   CANCER RISK FOLLOWING PERNICIOUS-ANEMIA [J].
BRINTON, LA ;
GRIDLEY, G ;
HRUBEC, Z ;
HOOVER, R ;
FRAUMENI, JF .
BRITISH JOURNAL OF CANCER, 1989, 59 (05) :810-813
[7]  
CAHILL RJ, 1993, ACTA GASTROENTEROL S, V56, P61
[8]  
CAMELS S, 1991, IARC SCI PUBL, V105, P187
[9]  
Caygill C P, 1991, Eur J Cancer Prev, V1, P35
[10]  
CAYGILL CPJ, 1986, LANCET, V1, P929